Enovis (ENOV) to Release Quarterly Earnings on Wednesday

Enovis (NYSE:ENOV) is expected to be announcing its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $555.14 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Enovis Trading Up 0.9 %

Enovis stock opened at $44.30 on Wednesday. The stock has a market cap of $2.52 billion, a P/E ratio of -20.23 and a beta of 1.94. Enovis has a fifty-two week low of $38.27 and a fifty-two week high of $65.03. The firm’s fifty day moving average price is $45.30 and its 200-day moving average price is $44.33. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $65.00 price target on shares of Enovis in a report on Thursday, November 7th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $64.83.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.